FDA approves new pneumonia vaccine with wider reach

Prevnar 13 protects against more strains of bacteria than the existing vaccine and is expected to produce a sharp drop in infections. A CDC panel meets today on whether to urge widespread use. The U.S. Food and Drug Administration on Wednesday approved a new pneumococcal vaccine that protects against more strains of bacteria than the existing one and is expected to produce a...

Read the whole article on LA Times - Science

More from LA Times - Science